Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2012101125) SPECIFIC ANTIBODIES AGAINST HUMAN CXCL4 AND USES THEREOF
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS:

I . An isolated CXCL4 antibody which is obtainable from the hybridoma accessible under CNCM deposit number 1-4310.

2. An isolated CXCL4 antibody which comprises the CDRs sequences of the antibody according to claim 1.

3. An antibody which comprises a variable light chain (VL) comprising the CDRs of the VL chain of an antibody according to claim 1 and a variable heavy chain (VH) comprising the CDRs of the VH chain of an antibody according to claim 1.

4. The antibody according to claim 3 comprising the VL chain of the antibody according to claim 1 and the VH chain of the antibody according to claim 1.

5. The antibody of claim 4 wherein said antibody is a chimeric antibody.

6. The antibody according to claim 2 or 3, wherein said antibody is a humanized antibody.

7. The antibody according to any of claims 1 to 6 which is an antibody fragment directed against CXCL4.

8. The antibody according to claim 7 wherein said fragment is selected from the group consisting of Fv, Fab, F(ab')2, Fab', dsFv, scFv, sc(Fv)2 and diabodies.

9. A nucleic acid comprising a sequence encoding the antibody according to any of claims 1 to 8.

10. A vector comprising a nucleic acid according to claim 9.

I I . A host cell comprising a nucleic acid according to claim 8 or a vector according to claim 9.

12. A pharmaceutical composition comprising the antibody according to any of claims 1 to 8 and a pharmaceutically acceptable carrier.

13. The antibody according to any one claims 1 to 8 which is labelled with a detectable molecule or substance.

14. A method for detecting CXCL4 in a biological sample comprising a step of contacting said biological sample with the antibody according to any one of claims 1 to 8, or a labelled antibody or fragment thereof according to claim 13.

15. The antibody according to any one claims 1 to 8 for use as drug.